vs
CSW INDUSTRIALS, INC.（CSW）とペナンブラ（PEN）の財務データ比較。上の社名をクリックして会社を切り替えられます
ペナンブラの直近四半期売上が大きい（$385.4M vs $233.0M、CSW INDUSTRIALS, INC.の約1.7倍）。ペナンブラの純利益率が高く（12.3% vs 4.4%、差は7.9%）。ペナンブラの前年同期比売上増加率が高い（22.1% vs 20.3%）。ペナンブラの直近四半期フリーキャッシュフローが多い（$68.0M vs $22.7M）。過去8四半期でペナンブラの売上複合成長率が高い（17.6% vs 5.1%）
ペナンブラ社は2004年にArani BoseとAdam Elsesserによって設立された米国の医療機器メーカーで、本社はカリフォルニア州アラメダに所在します。脳卒中や動脈瘤などの血管疾患向けの介入治療用機器の開発・製造を主力事業として展開しています。
CSW vs PEN — 直接比較
売上が大きい
PEN
1.7倍大きい
$233.0M
売上成長率が高い
PEN
+1.8%の差
20.3%
純利益率が高い
PEN
純利益率が7.9%高い
4.4%
フリーキャッシュフローが多い
PEN
FCF $45.3M多い
$22.7M
2年売上CAGRが高い
PEN
2年複合成長率
5.1%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $233.0M | $385.4M |
| 純利益 | $10.3M | $47.3M |
| 粗利率 | 39.7% | 68.0% |
| 営業利益率 | 7.4% | 15.4% |
| 純利益率 | 4.4% | 12.3% |
| 売上前年比 | 20.3% | 22.1% |
| 純利益前年比 | -61.9% | 40.6% |
| EPS（希薄化後） | $0.62 | $1.20 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上CSWPEN
| Q4 25 | $233.0M | $385.4M | ||
| Q3 25 | $277.0M | $354.7M | ||
| Q2 25 | $263.6M | $339.5M | ||
| Q1 25 | $230.5M | $324.1M | ||
| Q4 24 | $193.6M | $315.5M | ||
| Q3 24 | $227.9M | $301.0M | ||
| Q2 24 | $226.2M | $299.4M | ||
| Q1 24 | $210.9M | $278.7M |
純利益CSWPEN
| Q4 25 | $10.3M | $47.3M | ||
| Q3 25 | $40.7M | $45.9M | ||
| Q2 25 | $40.9M | $45.3M | ||
| Q1 25 | $35.1M | $39.2M | ||
| Q4 24 | $26.9M | $33.7M | ||
| Q3 24 | $36.1M | $29.5M | ||
| Q2 24 | $38.6M | $-60.2M | ||
| Q1 24 | $31.8M | $11.0M |
粗利率CSWPEN
| Q4 25 | 39.7% | 68.0% | ||
| Q3 25 | 43.0% | 67.8% | ||
| Q2 25 | 43.8% | 66.0% | ||
| Q1 25 | 44.2% | 66.6% | ||
| Q4 24 | 41.4% | 66.8% | ||
| Q3 24 | 45.6% | 66.5% | ||
| Q2 24 | 47.5% | 54.4% | ||
| Q1 24 | 44.4% | 65.0% |
営業利益率CSWPEN
| Q4 25 | 7.4% | 15.4% | ||
| Q3 25 | 20.5% | 13.8% | ||
| Q2 25 | 20.8% | 12.0% | ||
| Q1 25 | 19.5% | 12.4% | ||
| Q4 24 | 15.3% | 13.6% | ||
| Q3 24 | 22.6% | 11.7% | ||
| Q2 24 | 24.3% | -27.0% | ||
| Q1 24 | 21.0% | 4.3% |
純利益率CSWPEN
| Q4 25 | 4.4% | 12.3% | ||
| Q3 25 | 14.7% | 12.9% | ||
| Q2 25 | 15.5% | 13.3% | ||
| Q1 25 | 15.2% | 12.1% | ||
| Q4 24 | 13.9% | 10.7% | ||
| Q3 24 | 15.8% | 9.8% | ||
| Q2 24 | 17.1% | -20.1% | ||
| Q1 24 | 15.1% | 3.9% |
EPS（希薄化後）CSWPEN
| Q4 25 | $0.62 | $1.20 | ||
| Q3 25 | $2.41 | $1.17 | ||
| Q2 25 | $2.43 | $1.15 | ||
| Q1 25 | $2.05 | $1.00 | ||
| Q4 24 | $1.60 | $0.88 | ||
| Q3 24 | $2.26 | $0.75 | ||
| Q2 24 | $2.47 | $-1.55 | ||
| Q1 24 | $2.03 | $0.28 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $186.9M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $1.1B | $1.4B |
| 総資産 | $2.3B | $1.8B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資CSWPEN
| Q4 25 | $40.2M | $186.9M | ||
| Q3 25 | $31.5M | $321.0M | ||
| Q2 25 | $38.0M | $421.8M | ||
| Q1 25 | $225.8M | $376.1M | ||
| Q4 24 | $213.8M | $324.4M | ||
| Q3 24 | $273.2M | $280.5M | ||
| Q2 24 | $18.9M | $288.3M | ||
| Q1 24 | $22.2M | $223.1M |
総負債CSWPEN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
株主資本CSWPEN
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.0B | $1.2B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $650.2M | $1.2B | ||
| Q1 24 | $615.7M | $1.2B |
総資産CSWPEN
| Q4 25 | $2.3B | $1.8B | ||
| Q3 25 | $1.5B | $1.7B | ||
| Q2 25 | $1.5B | $1.7B | ||
| Q1 25 | $1.4B | $1.6B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.4B | $1.5B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $1.0B | $1.6B |
負債/資本比率CSWPEN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $86.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $68.0M |
| FCFマージンFCF / 売上 | 9.8% | 17.7% |
| 設備投資強度設備投資 / 売上 | 2.6% | 4.8% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 1.83× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $174.9M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローCSWPEN
| Q4 25 | $28.9M | $86.5M | ||
| Q3 25 | $61.8M | $58.3M | ||
| Q2 25 | $60.6M | $44.9M | ||
| Q1 25 | $27.3M | $49.0M | ||
| Q4 24 | $11.6M | $51.1M | ||
| Q3 24 | $66.8M | $56.5M | ||
| Q2 24 | $62.7M | $22.6M | ||
| Q1 24 | $22.4M | $38.3M |
フリーキャッシュフローCSWPEN
| Q4 25 | $22.7M | $68.0M | ||
| Q3 25 | $58.7M | $42.0M | ||
| Q2 25 | $57.7M | $29.4M | ||
| Q1 25 | $22.8M | $35.5M | ||
| Q4 24 | $8.5M | $45.7M | ||
| Q3 24 | $61.3M | $51.0M | ||
| Q2 24 | $59.6M | $18.1M | ||
| Q1 24 | $17.5M | $32.5M |
FCFマージンCSWPEN
| Q4 25 | 9.8% | 17.7% | ||
| Q3 25 | 21.2% | 11.8% | ||
| Q2 25 | 21.9% | 8.7% | ||
| Q1 25 | 9.9% | 11.0% | ||
| Q4 24 | 4.4% | 14.5% | ||
| Q3 24 | 26.9% | 16.9% | ||
| Q2 24 | 26.3% | 6.0% | ||
| Q1 24 | 8.3% | 11.7% |
設備投資強度CSWPEN
| Q4 25 | 2.6% | 4.8% | ||
| Q3 25 | 1.1% | 4.6% | ||
| Q2 25 | 1.1% | 4.6% | ||
| Q1 25 | 2.0% | 4.2% | ||
| Q4 24 | 1.6% | 1.7% | ||
| Q3 24 | 2.4% | 1.8% | ||
| Q2 24 | 1.4% | 1.5% | ||
| Q1 24 | 2.3% | 2.1% |
キャッシュ転換率CSWPEN
| Q4 25 | 2.81× | 1.83× | ||
| Q3 25 | 1.52× | 1.27× | ||
| Q2 25 | 1.48× | 0.99× | ||
| Q1 25 | 0.78× | 1.25× | ||
| Q4 24 | 0.43× | 1.52× | ||
| Q3 24 | 1.85× | 1.91× | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | 3.48× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
